Title
Category
Credits
Event date
Cost
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
The successful management of obesity—a complex, chronic and relapsing disease—through sustainable weight loss interventions can greatly improve individuals’ overall health status and diminish the severity of concomitant diseases such as diabetes. This activity will provide an overview of obesity and diabetes that describes effective multi-interventional approaches to weight loss and, importantly, highlights the role of incorporated lifestyle changes in promoting the likelihood of weight loss success and improved health outcomes. The conversational style of this activity will encourage discussion around obesity-care planning and examine the factors that must be considered due to the chronic and relapsing characteristics of this disease.
  • Disease management
  • Transplantation
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This session examines the experiences and perspective of a transplant surgeon describing his personal journey as a transplant recipient.
  • Behavioral health
  • Disease management
  • Palliative care and hospice
  • 2.00 AMA - Physicians
  • 2.00 ANCC - Nurses
  • 2.00 Attendance - General Attendance
$0.00
Activity descriptionConversations that provide patients who have serious and life-threatening illnesses with the opportunity to make informed choices reflecting their goals, values and care preferences are a critical part of their care. These discussions can help ensure that seriously ill patients receive care that is consistent with their wishes and provide guidance to enhance family well-being and improve the patient’s quality of life.
  • Disease management
  • Oncology
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This activty will discuss how precision medicine is quickly becoming a standard of care in the field of oncology and will explore recent advances in such applications as gene sequencing, molecular diagnostic assays, liquid biopsies and biomarkers. Future applications and innovations in precision medicine tailored to the treatment of specific cancers will also be examined.
  • Disease management
  • Rare diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This presentation addresses the needs for improved access to care, new advances in rare-disease diagnosis, and treatments emerging with the rise of personalized precision medicine. New possibilities for collaboration among medicine, research and drug-development organizations are also discussed.
  • Disease management
  • Health equity
  • Rare diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
$0.00
This activity will explore recent advances in the diagnosis and treatment of leukodystrophies, including current clinical trials. It will also share insights and perspectives from individuals and their family/caregiver(s) and provide strategies to support their well-being.
  • Disease management
  • Health equity
  • Rare diseases
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 ASWB - Social Workers
$0.00
Living with a rare disease impacts individuals and their family/caregivers, both physically and mentally. This podcast will share insights and perspectives directly from Erica Barnes and provide strategies that the interprofessional health care team can utilize to better support those impacted by rare diseases such as leukodystrophies.
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This educational webcast is designed to enhance primary care providers’ competency in managing headaches with a focus on evidence-based approaches. Participants will engage in a comprehensive review of migraine pathophysiology to better recognize and differentiate migraine symptoms. The session will examine traditional therapies for migraine, both acute and preventive, and introduce cutting-edge anti-calcitonin gene-related peptide (CGRP) targeted therapies. It will compare the efficacy and application of these treatments, enabling informed decision-making in clinical practice. The program will also explore the application of anti-CGRP therapies beyond migraines, considering their role in treating a variety of headache and facial-pain conditions.
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
05/08/2024
$0.00
Osteoporosis can significantly impact an individual’s morbidity, mortality and quality of life due to increased fracture risks caused by decreasing bone density. This educational webcast will focus on the necessary skills to effectively identify, diagnose, and manage osteoporosis, highlighting the latest screening recommendations, diagnostic criteria, and evidence-based treatment strategies. Optimal management approaches and monitoring recommendations that minimize potential adverse effects of therapy will be discussed, and participants will gain enhanced competency in tailoring interventions based on patient characteristics and disease severity.

Pages